A trial comparing Tarceva (erlotinib) to Cometriq (cabozantinib) showed modest benefit for EGFR wild type patients, but the challenging side effect...
A trial comparing Tarceva (erlotinib) to Cometriq (cabozantinib) showed modest benefit for EGFR wild type patients, but the challenging side effect...
Squamous cell carcinoma patients have limited options. Data presented at ASCO 2015 showed positive patient outcomes with Gilotrif (afatinib) vs...
Squamous cell carcinoma patients have limited options. Data presented at ASCO 2015 showed positive patient outcomes with Gilotrif (afatinib) vs...
The current standard of care for SCLC shows limited results with high toxicities. Drs. Soria, Gandhi, and West discuss new ASCO 2015 data that show...
I have bad pain from an adrenal gland met. My doc says I shouldn’t have pain it’s too small roughly 2 x 1.5 cm has anyone had this stabbing pain? I...
Hello Dr. West and Grace community, My husband is a 34-year old, never-smoker, stage IV patient (bone and lymph node mets). He was negative for...
Hello Dr. West and Grace community, My husband was diagnosed 10 months ago at stage IV (bone and lymph node mets). He was a previously healthy, never...
Recently diagnosed with T1cN0M0 adenocarcinoma. Path indicates KRAS positive, with 40% solid component, 30%acinar, 30% micropapilllary. Had lobectomy...
Hello community! We would like to see what you, our community, would like to see on GRACE. In this new year, we are planning big things - we will have...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.